Alliance Pharma PLC Share Options (6773E)

TIDMAPH

RNS Number : 6773E

Alliance Pharma PLC

11 April 2014

 
 For immediate release   11 April 2014 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 11 April 2014 it awarded the following options over ordinary shares of the Company to certain Directors.

 
 Name            Position     Number      Exercise     Date of    Percentage 
                               of Share    price        vesting    of issued 
                               Options     per Share               ordinary 
                               Awarded                             share 
                                                                   capital 
--------------  -----------  ----------  -----------  ---------  ----------- 
 Anthony         Executive                             11 April 
  Booley          Director    144,200     33.75p        2017      0.055 
--------------  -----------  ----------  -----------  ---------  ----------- 
 Peter           Executive                             11 April 
  Butterfield     Director    144,200     33.75p        2017      0.055 
--------------  -----------  ----------  -----------  ---------  ----------- 
 Richard         Finance                               11 April 
  Wright          Director    144,200     33.75p        2017      0.055 
--------------  -----------  ----------  -----------  ---------  ----------- 
 

For further information:

 
                                          + 44 (0) 1249 
 Alliance Pharma plc                             466966 
 John Dawson, Chief Executive 
 Richard Wright, Finance Director 
 www.alliancepharma.co.uk 
                                       + 44 (0) 20 7466 
 Buchanan                                          5000 
 Mark Court / Fiona Henson / 
  Sophie Cowles 
 
                                       + 44 (0) 20 7260 
 Numis Securities Limited                          1000 
 Nominated Adviser: Michael 
  Meade / Oliver Cardigan / Freddie 
  Barnfield 
 Corporate Broking: David Poutney 
 

Notes to editors:

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKDDBNBKDPQD